Support program for young adults recovering from opioid use disorder
The Youth Opioid Recovery Support (YORS) Intervention: An Assertive Community Treatment Model for Improving Medication Adherence in Young Adults With Opioid Use Disorder
This study is testing a new support program to help young adults aged 18-28 with opioid use disorder stick to their treatment and feel more engaged in their recovery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 28 Years |
| Sex | All |
| Sponsor | Potomac Health Foundations Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Trial ID | NCT04173416 on ClinicalTrials.gov |
What this trial studies
The Youth Opioid Recovery Support (YORS) intervention aims to improve medication adherence and treatment engagement among young adults aged 18-28 with opioid use disorder (OUD). This innovative model includes home delivery of medication, family involvement in treatment planning, assertive outreach via text and social media, and contingency management to incentivize adherence. The study will refine the YORS approach through stakeholder input and pilot testing, followed by a randomized controlled trial to evaluate its efficacy. The goal is to develop effective strategies to address the opioid crisis in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18-28 diagnosed with opioid use disorder who are willing to engage in treatment with extended release naltrexone or buprenorphine.
Not a fit: Patients with psychiatric or medical instability or those living more than 75 miles from the treatment center may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance treatment adherence and outcomes for young adults struggling with opioid use disorder.
How similar studies have performed: Preliminary results from a small pilot randomized clinical trial of the YORS model have shown promising outcomes, indicating potential for success in larger studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-28 * OUD diagnosis * Willing (intending) to receive treatment with XR-NTX or XR-BUP under the care of a MTC physician/nurse practitioner * Willingness to designate family member (or other suitable treatment significant other) for treatment involvement (i.e., a treatment significant other; TSO) Exclusion Criteria: * Psychiatric or medical instability (e.g., suicidality, psychosis, Sickle Cell disease with frequent crises) that would preclude participation in the trial * Living situation (location greater than 75 miles from the center, homelessness) that would preclude participation in the trial
Where this trial is running
Baltimore, Maryland
- Mountain Manor Treatment Center — Baltimore, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Marc Fishman, MD — Maryland Treatment Centers
- Study coordinator: Marc Fishman, MD
- Email: mjfishman@comcast.net
- Phone: 410-233-1400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.